细胞周期失调是肿瘤重要的标志之一，生物信息学分析结果表明，Trigger转座子衍生蛋白1（TIGD1）在临床肝癌组织中高表达且与细胞周期相关，但相关机制未知。为了探究TIGD1调控肝癌细胞生长的具体机制，首先，利用shRNA质粒构建靶向敲低TIGD1的肝癌细胞系Hep3B，并分析TIGD1敲低对肝癌细胞生长的影响，结果表明细胞生长受阻；接着，通过细胞流式技术分析TIGD1敲低对肝癌细胞周期进程的影响，结果显示，TIGD1敲低的Hep3B细胞系的细胞周期进程主要阻滞于G2/M期；然后，通过免疫沉淀（IP）实验验证TIGD1可能发生相互结合的蛋白分子，结果表明，TIGD1可能与Aurora激酶相互作用蛋白1（AURKAIP1）存在相互结合，进一步的Co-IP实验证实了TIGD1和AURKAIP1之间的相互作用。已知AURKAIP1可调控Aurora激酶A（AURKA）的蛋白酶体降解途径，AURKA是一种有丝分裂调控蛋白，与细胞周期进程密切相关。文中进一步探究TIGD1对AURKA蛋白水平的影响，实验结果表明，在TIGD1敲低的情况下，AURKA在Hep3B细胞系中的蛋白水平明显下调，mRNA水平没有明显变化。综上所述，TIGD1可能通过调控AURKA在肝癌细胞中的转录后水平来影响细胞周期进程，从而影响肝癌的发生发展。

Cell cycle dysregulation is one of the most important hallmarks of cancer. Bioinformatics studies have suggested that trigger transposable element-derived 1 (TIGD1) is expressed at higher levels in the tumor tissues from the clinical hepatocellular carcinoma (HCC) samples and may be related to the cell cycle. However, the underlying mechanism is unclear. To explore the specific mechanism of TIGD1 regulating the growth of hepatocellular carcinoma cells, this paper first analyzed the growth of HCC cell line Hep3B with TIGD1 knockdown by using shRNA plasmid. The results show that cell growth is inhibited. Then, cell cycle analysis by flow cytometry was used to investigate the effect of TIGD1 knockdown on cell cycle of HCC. The results show that the cell cycle progression of the Hep3B cell line is mainly blocked in the G2/M phase. Next, Immunoprecipitation (IP) experiments were used to verify the protein molecules with which TIGD1 might interact. And the results show that TIGD1 may be bound to Aurora kinase interacting protein 1 (AURKAIP1). Further, the Co-IP experiment confirmed the interaction between TIGD1 and AURKAIP1. AURKAIP1 is known to regulate the proteasomal degradation pathway of Aurora kinase A (AURKA), and AURKA is a mitotic regulatory protein that is closely associated with cell cycle progression. The paper further explored the effect of TIGD1 on AURKA protein levels, and the results show that TIGD1 knockdown obviously decreases the protein level of AURKA without affecting its mRNA level in Hep3B cells. In conclusion, TIGD 1 may affect cell cycle progression by regulating the post-transcriptional levels of AURKA in HCC cells, thus affecting the development of HCC.